Search Results - "Healy, Connor P."

High-throughput enrichment and isolation of megakaryocyte progenitor cells from the mouse bone marrow by Bush, Lucas M., Healy, Connor P., Marvin, James E., Deans, Tara L.

“…Megakaryocytes are a rare population of cells that develop in the bone marrow and function to produce platelets that circulate throughout the body and form…”
Get full text

Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma by Kovacsovics-Bankowski, Magdalena, Sweere, Johanna M, Healy, Connor P, Sigal, Natalia, Cheng, Li-Chun, Chronister, William D, Evans, Shane A, Marsiglio, John, Gibson, Berit, Swami, Umang, Erickson-Wayman, Alyssa, McPherson, Jordan P, Derose, Yoko S, Eliason, Annaleah Larson, Medina, Carlos O, Srinivasan, Ramji, Spitzer, Matthew H, Nguyen, Ngan, Hyngstrom, John, Hu-Lieskovan, Siwen

“…BackgroundImmune-related adverse events (irAEs) are major barriers of clinical management and further development of immune checkpoint inhibitors (ICIs) for…”
Get full text

Biological Cells as Therapeutic Delivery Vehicles by Bush, Lucas M., Healy, Connor P., Javdan, Shwan B., Emmons, Jonathan C., Deans, Tara L.

“…One of the significant challenges remaining in the field of drug delivery is insufficient targeting of diseased tissues or cells. While efforts to perform…”
Get full text

Abstract 2138: Immune features of irAEs and aPD1 response in urothelial cancer patients of the RADIOHEAD study, as detected in blood by mass cytometry immune profiling by Healy, Connor P., Sweere, Johanna M., Liang, Samantha I., Sigal, Natalia, Enrico, Elizabeth, Cheng, Li-Chun, Lucas, Anastasia, Thompson, Marshall A., Da Silva, Diane M., Jarrell, Justin A., Srinivasan, Ramji, Spitzer, Matthew H., Nguyen, Ngan, Spencer, Christine N.

“…Checkpoint immunotherapies (CPI) have resulted in long lasting clinical responses; however, CPI treatment comes with the risk of immune-related adverse events…”
Get full text